Vax Before Cancer

 / January 19th, 2022

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Jan 19 • 9:11 am CST
The JAMA Network published an Orginal Investigation on January 18, 2022 that found that U.S. Preventive Services Task Force guideline-concordant cervical cancer screening rates decreased between 2005 and 2019, before the COVID-19 pandemic. The most common...
Jan 19 • 8:12 am CST
California-based ImmunityBio, Inc. announced interim results in its metastatic pancreatic cancer trial (QUILT 88), showing that the overall survival rate for patients doubled compared to the historical survival rate of three months after two prior lines...
Jan 18 • 4:02 pm CST
The Harvard Business Review (HBR) published an article on January 17, 2022, that while the rate of new cancer cases is similar for white and Black patients, the death rate for Black cancer patients continues to...
Jan 18 • 5:31 am CST
Cancer Research UK, Vaccitech plc, and the Ludwig Institute for Cancer Research today announced the first patient dosed in the MAGE clinical trial, which is testing a novel immunotherapeutic, VTP-600, in patients with the most common...
Jan 17 • 11:08 am CST
California-based Allogene Therapeutics, Inc. announced on January 10, 2022, that the U.S. Food and Drug Administration (FDA) had removed the clinical hold on the Company's five AlloCAR T clinical trials. Allogene will be working with clinical...

For more articles, try our search.